Nasal Cannula with Flow Restriction Channels for Nitric Oxide Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current NO delivery systems for ambulatory patients are cumbersome and inefficient, requiring electromechanical parts and sensors, which increase size and limit portability, and often deliver NO too late in the inhalation cycle, leading to exhalation of a significant fraction of the gas, and are not suitable for long-term therapy due to the risk of NO2 production when NO comes into contact with oxygen.

Innovation Solution

A nasal cannula assembly with a deformable-wall reservoir and flow restriction channels that separates NO and oxygen compartments, allowing NO to be delivered efficiently by minimizing contact with oxygen until inhalation, eliminating the need for sensors and electromechanical parts, and ensuring minimal exhalation of NO.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If pulsed delivery systems with sensors and electromechanical valves are used, then NO can be delivered sequenced to patients, but the system size increases and portability is limited

Engineering Contradiction:
ImproveNO delivery efficiencyVSAvoidsystem size
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent removes sensors and electromechanical valves from the system, extracting only the essential function of delivering NO during inhalation by using passive flow restriction channels and patient breathing dynamics to control gas flow timing

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The system uses the patient's own inhalation flow to drive the delivery mechanism, where the patient's breathing creates the pressure differential that opens the flow restriction channel and triggers NO delivery without external sensing or actuation

Inventive Principle:
Principle #25Self-service

2Device complexity

If NO is delivered late in the inhalation cycle, then the delivery system is simple, but a significant fraction of NO is exhaled

Engineering Contradiction:
Improvedelivery system simplicityVSAvoidNO exhalation loss
Core Design Contradiction:
Device complexityVSLoss of energy

Solution Approach 1:

The flow restriction channel is positioned and sized to open at the very beginning of inhalation, delivering NO at the optimal moment before the patient's tidal volume fills, ensuring maximum utilization of the delivered gas without requiring complex timing control

Inventive Principle:
Principle #10Preliminary action

3Device complexity

If NO and oxygen are mixed early, then the delivery system is simple, but toxic NO2 is produced

Engineering Contradiction:
Improvegas mixing simplicityVSAvoidNO2 toxicity
Core Design Contradiction:
Device complexityVSObject-affected harmful factors

Solution Approach 1:

The system divides the gas delivery into separate compartments: a first compartment delivers oxygen-containing gas, and a second compartment delivers NO-containing gas, with flow restriction channels controlling their separate paths until they mix only at the point of patient inhalation

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The flow restriction channel acts as an intermediary control element that regulates the mixing of NO and oxygen gases, allowing precise control of their interaction to minimize residence time and NO2 formation while ensuring therapeutic delivery

Inventive Principle:
Principle #24Intermediary (Mediator)

4Device complexity

If long residence time of NO with oxygen is allowed, then the system is simpler, but NO2 concentration increases

Engineering Contradiction:
Improvesystem simplicityVSAvoidNO2 concentration
Core Design Contradiction:
Device complexityVSObject-generated harmful factors

Solution Approach 1:

The system minimizes the residence time of NO with oxygen by rushing the mixing process through the flow restriction channel directly to the patient interface, reducing the time available for NO2 formation to below detectable levels while maintaining therapeutic NO delivery

Inventive Principle:
Principle #21Skipping (Rushing through)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The nasal cannula assembly effectively delivers NO over extended periods, minimizing anatomical dead volume and NO2 production, providing a portable and efficient solution for ambulatory NO therapy without the need for electronic sensors or processing units.

Implementation Method 1

permitting a passage of gas from the second compartment to the first compartment in a reduced pressure state during an inhalation phase and preventing a majority of flow of the second gas from the second compartment to first compartment in a higher pressure state, during an exhalation phase

Methodology Applied
Scientific EffectPressure differential: Pressure Gradient

Implementation Method 2

a deformable wall forming a part of the boundary between the second compartment and the room atmosphere such that the Compliance of the second compartment is not less than 5 ml/cm H2O while filling but is less than 0.1 ml/cm H2O once the second compartment is full

Methodology Applied
Scientific EffectDeformable wall expansion: Elasticity

Implementation Method 3

a first compartment and a second compartment separated by a separation wall, the first compartment comprising a first inlet for introducing a first gas into the first compartment, the second compartment comprising a second inlet for introducing a second gas into the second compartment

Methodology Applied
Scientific EffectPhysical separation: Physical Containment

Data Source

PatentUS9522248B2Breathing assistance apparatus for delivery of nitric oxide to a patient by means of a nasal cannula assembly with flow control passage
Publication Date: 2016.12.20 LAIR LIQUIDE SA POUR LETUDE & LEXPLOITATION DES PROCEDES GEORGES CLAUDE
  • US9522248B2 patent drawing
  • US9522248B2 patent drawing
  • US9522248B2 patent drawing

AI summary

The invention concerns a breathing assistance apparatus having a source of Nitric Oxide in fluid communication with a nasal cannula assembly (10) adapted to deliver gases to a patient comprising a first compartment (1) and a second compartment (2) separated by a separation wall (6); a pair of nasal prongs (5) in fluid communication with the first compartment (1); the first compartment (1) comprising a first inlet (11) for introducing a first gas into said first compartment (1); the second compartment (2) comprising a second inlet (2) for introducing a second gas into said second compartment (2); and the separation wall (6) comprising at least one flow restriction element (35) for controlling the passage of gas from the second compartment (2) to the first compartment (1).